Press release
Antifibrinolytic Drugs Market: Report Scope and Market Segmentation 2017 - 2025
Growth in healthcare investments, the prevalence of angioedema and growing high-risk geriatric population, are the major factors driving the global market growth for angioedema treatment. In the next few years, the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.
On the basis of Indications, the Global Antifibrinolytic Drugs market can be segmented into,
Gynecology
Menorrhagia
Pregnancy
Parturition
Gynecological surgery
Gastrointestinal (GI) bleeding
Dental surgery
Haemorrhage
Bleeding disorders
Hereditary angioedema
Fibrinolytic response testing
Surgeries
Cardiac
Orthopedic
Liver
Neurosurgery
On the basis of Drug Types, the Global Antifibrinolytic Drugs market can be segmented into,
Amicar
Aminocaproic acid
Aprotinin
Cyklokapron
Fibrinogen, human
Lysteda
RiaSTAP
Tranexamic acid injection
Tranexamic acid oral
Trasylol
On the basis of End User, the Global Antifibrinolytic Drugs market can be segmented into,
Hospitals
Ambulatory Surgical Centers
Clinics
Healthcare Specialty processes
Others
On the basis of Region, the Global Antifibrinolytic Drugs market can be segmented into,
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For treating menorrhagia, Tranexamic acid is widely used and is also recommended by the current National Institute for Health and Care Excellence guidelines. Tranexamic acid is effective in decreasing the blood loss by almost 40-50%. Etamsylate is used just occasionally to treat menorrhagia.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/14035
Geographically, North America is the dominating region in the Antifibrinolytic Drugs market owing to the advancing strict rules at the work place in this region, also due to a large number of aging population and broad technical applications of Antifibrinolytic Drugs in the region. Also, rising awareness of Antifibrinolytic Drugs has fueled the Antifibrinolytic Drugs market.The US holds the prominent market in the Antifibrinolytic Drugs market in North America trailed by Europe including Germany, France, and the UK. The Asian market for Antifibrinolytic Drugs is also expected to witness a high CAGR during the coming years. Increased foreign investments in this region will also boost the Antifibrinolytic Drugs market ahead. China and Japan are projected to be the fastest-growing in the Antifibrinolytic Drugs market.
Currently, the global Antifibrinolytic Drugs market is highly competitive owing to the involvement of many established players. Some of the key players in the global Antifibrinolytic Drugs market are Aurobindo Pharma Ltd, Acic Fine Chems, Akorn and Xanodyne Pharmaceuticals.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antifibrinolytic Drugs Market: Report Scope and Market Segmentation 2017 - 2025 here
News-ID: 982244 • Views: …
More Releases from Persistence Market Research
Automotive MRO Industry Forecast to Hit US$ 171.3 Billion by 2032, Advancing at …
The global Automotive MRO (Maintenance, Repair, and Operations) market is experiencing steady growth, driven by the increasing need for vehicle maintenance services and aftermarket support across passenger and commercial vehicles. According to Persistence Market Research, the market is expected to reach a value of US$171.3 Bn by 2032, up from US$126.7 Bn in 2025, reflecting a CAGR of 4.4% during the forecast period of 2025 to 2032. The market growth…
Global Automotive Horn Industry Forecast at US$3.3 Billion by 2032, Led by Compa …
The automotive horn market plays a crucial yet often understated role in the global automotive ecosystem, serving as a primary safety and communication component across vehicle categories. Automotive horns are mandated safety devices designed to alert pedestrians, cyclists, and other vehicles, thereby reducing the risk of collisions in diverse traffic environments. As global vehicle production and on-road vehicle density continue to rise, the relevance of reliable and effective horn systems…
Aircraft Flight Control System Market to Hit US$ 45.7 Billion by 2033 as Key Pla …
The Aircraft Flight Control System Market represents a critical pillar of the global aerospace and aviation ecosystem, enabling safe, efficient, and precise aircraft operations across commercial, military, and general aviation platforms. Flight control systems are responsible for managing aircraft stability, maneuverability, and responsiveness by translating pilot or automated inputs into aerodynamic actions. As aviation technology continues to evolve, these systems have transformed from purely mechanical assemblies into highly integrated digital…
U.S. & Canada Bicycle Accessories Market to Hit US$3.7 Billion by 2033 as Key Pl …
The U.S. & Canada bicycle accessories market is undergoing a notable transformation as cycling continues to gain traction as a preferred mode of transportation, fitness activity, and recreational pursuit. Changing urban mobility patterns, increasing focus on personal health, and a growing emphasis on eco-friendly transportation are reshaping the demand landscape for bicycle accessories across North America. From safety gear and lighting systems to advanced smart accessories, the market is evolving…
More Releases for Antifibrinolytic
Antifibrinolytic Drugs Market | Pipeline Advancements & Clinical Trials Boost Ma …
DataM Intelligence unveils its latest report on the "Antifibrinolytic Drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming…
Increasing Road Accidents Fuel Growth in Antifibrinolytic Drug Market: A Signifi …
The Antifibrinolytic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Antifibrinolytic Drugs Market Size and Projected Growth Rate?
Over the past few years, there has been robust growth in the size of the antifibrinolytic drugs market. The growth from $16.82 billion in…
Antifibrinolytic Drugs Market Expected to Reach $19,333 Million by 2026 | Top Re …
According to a new report published by Allied Market Research, titled, "Antifibrinolytic Drugs Market by Indication and End User: Global opportunity analysis and industry forecast, 2019-2026," the global antifibrinolytic drugs market size is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026, in terms of value.
Antifibrinolytics are one of the most commonly used drugs to prevent fibrinolysis by blocking the activation of plasminogen…
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What market dynamics are playing a key role in accelerating the growth of the antifibrinolytic drugs market?
The escalating rate of road mishaps projects an upward trajectory for the antifibrinolytic drugs market. Causes for this surge in road accidents range from smartphone usage, excessive speed, driving while intoxicated, and poor vehicle upkeep. Antifibrinolytic medications have a critical role in managing hemorrhage in victims of road crashes by consolidating blood clots, curtailing…
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What Are the Market Size and Growth Forecast for the Antifibrinolytic Drugs Market?
In the past few years, there has been a significant expansion in the size of the antifibrinolytic drugs market. The market, which was valued at $16.82 billion in 2024, is projected to rise to $17.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The surge in this market over the historical period is largely…
Antifibrinolytic Drugs Market Size, Share, Trends, Global Demand, Growth, Opport …
The latest research study "Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on…
